tiprankstipranks
Sensei Biotherapeutics (SNSE)
NASDAQ:SNSE
US Market

Sensei Biotherapeutics (SNSE) Income Statement

Compare
191 Followers

Sensei Biotherapeutics Income Statement

Last quarter (Q3 2024), Sensei Biotherapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Sensei Biotherapeutics's net income was $-7.25M. See Sensei Biotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -571.00K$ -1.81M$ -685.00K$ -209.00K$ -73.00K
Operating Expenses
$ 37.06M$ 50.19M$ 37.48M$ 18.71M$ 12.44M
Depreciation and Amortization
$ 3.68M$ 1.81M$ 685.00K$ 209.00K$ 73.00K
EBITDA
$ -33.39M$ -46.56M$ -36.80M$ -18.50M$ -12.36M
Operating Income
$ -37.06M$ -50.19M$ -37.48M$ -19.45M$ -12.44M
Other Income/Expenses
$ 2.96M$ 1.60M$ 688.00K$ -649.00K$ -4.30M
Pretax Income
$ -34.10M$ -48.59M$ -36.79M$ -20.10M$ -16.74M
Net Income
$ -34.10M$ -48.81M$ -37.46M$ -20.63M$ -19.00M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.22$ -1.59$ -1.35$ -0.67$ -0.65
Diluted EPS
$ -1.22$ -1.59$ -1.35$ -0.67$ -0.65
Weighted Average Shares Outstanding
27.95M 30.70M 27.71M 30.59M 29.33M
Weighted Average Shares Outstanding (Diluted)
27.95M 30.70M 27.71M 30.59M 29.33M
Currency in USD

Sensei Biotherapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis